Skip to main content

Event Details

Summit Therapeutics Presents at the Citi 2024 Global Healthcare Conference

December 4, 2024 8:45 AM ET

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).